Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Imhoff John E
   2. Issuer Name and Ticker or Trading Symbol
GUIDED THERAPEUTICS INC [GTHP] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
3215 SHRINE ROAD, SUITE 6		 3. Date of Earliest Transaction (Month/Day/Year)
05/29/2015
(Street)

BRUNSWICK, GA 31520		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/29/2015   P   18,752 A (1) 9,904,725 D  
Common Stock 06/30/2015   A   113,636 A (2) 9,885,973 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options $ 0.1 05/29/2015   A   600,000   05/29/2015 05/28/2025 Common Stock 600,000 (3) 600,000 D  
Tranche A Warrants $ 1.08 06/19/2015   S     367,647 05/22/2013 05/22/2018 Common Stock 367,647 (4) 0 D  
Tranche B Warrants $ 0.104 06/19/2015   S     3,797,789 05/22/2013 05/22/2018 Common Stock 3,797,789 (4) 0 D  
Tranche A Warrants $ 0.104 06/19/2015   P   367,647   05/22/2013 05/22/2018 Common Stock 367,647 (4) 367,647 D  
Tranche B Warrants $ 0.09 06/19/2015   P   3,797,789   05/22/2013 05/22/2018 Common Stock 3,797,789 (4) 3,797,789 D  
Warrants $ 0.225 06/30/2015   S     58,935 12/02/2014 12/02/2019 Common Stock 58,935 (1) 0 D  
Warrants $ 0.11 06/30/2015   P   58,935   12/02/2015 12/02/2020 Common Stock 58,935 (1) 58,935 D  
Warrants $ 0.09 06/30/2015   P   58,935   12/02/2015 12/02/2020 Common Stock 58,938 (1) 58,935 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Imhoff John E
3215 SHRINE ROAD
SUITE 6
BRUNSWICK, GA 31520		   X   X    

Signatures

 /S/ Gene Cartwright - Attorney In Fact   07/17/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
(2) These shares were granted as dividend on the issuer's Series B preferred stock.
(3) These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.
(4) On June 19, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock in an exchange with the issuer.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.